Factors Influencing Vertical Transmission of Psittacine Bornavirus in Cockatiels (Nymphicus hollandicus)
by
and
Jessica Link
1,*,
Sibylle Herzog
2,
Anna Maria Gartner
1,
Bianca Bücking
1,
Matthias König
2 and
Michael Lierz
1 1
Clinic for Birds, Reptiles, Amphibians and Fish, Justus Liebig University Giessen, Frankfurter Str. 114, 35392 Giessen, Germany
2
Institute of Virology, Justus Liebig University Giessen, Schubertstr. 81, 35392 Giessen, Germany
*
Author to whom correspondence should be addressed.
Viruses 2022, 14(12), 2721; https://doi.org/10.3390/v14122721
Submission received: 6 September 2022
/
Revised: 17 November 2022
/
Accepted: 2 December 2022
/
Published: 6 December 2022
(This article belongs to the Section Animal Viruses)
Abstract
:The transmission of parrot bornavirus is still not fully understood. Although horizontal transmission through wounds can be one route, vertical transmission is still discussed. PaBV RNA and PaBV antigen were detected in psittacine embryos, but isolation of the virus failed, raising doubts about this route. In this study, cockatiels were infected either as adults (adult group) or during the first 6 days after hatching (juvenile group) and raised until sexual maturity to breed and lay eggs. A total of 92 eggs (adult group: 49, juvenile group: 43) were laid and incubated until day 17. The embryos and yolk samples were examined by RT-PCR for PaBV RNA and by infectivity assay for infectious virus. In the adult group, 14/31 embryos (45.2%) and 20/39 (51%) of the yolk samples demonstrated PaBV RNA in the PCR. Isolation of PaBV was not possible in any embryo of this group, but it was achieved in six yolk samples from one female. Anti-PaBV antibodies were detected in the yolk samples after seroconversion of all female parents. In the juvenile group, 22/29 embryos (74.9%) were positive for PaBV RNA. In 9/21 embryos (42.9%), PaBV isolation was possible. PaBV RNA was detected in 100% and infectious virus in 41% of the yolk samples. Anti-PaBV antibodies were detected in all yolk samples. For the first time, successful vertical transmission of PaBV was proven, but it seems to depend on the age when the parent birds are infected. Therefore, the age of the bird at time of infection may be an important factor in the occurrence of vertical transmission.
1. Introduction
Psittacines are one of the most endangered avian groups. Many species are nearly extinct according to the International Union for Conservation of Nature (IUCN). One of the most threatening infectious diseases in parrots is caused by parrot bornaviruses (PaBVs), which were first detected in 2008 [1,2]. PaBVs are the causative agent of the proventricular dilatation disease (PDD). Impaired gastro-intestinal function and symptoms affecting the central nervous system may appear as clinical signs [3].
Different infection trials suggested PaBVs as the causative agent for PDD, as birds developed clinical signs after being infected with various virus isolates [4,5]. Piepenbring et al. [6] fulfilled the Henle–Koch postulates for PaBVs by infecting nine cockatiels through intraveneous and intracerebral routes. All those studies had in common the use of parenteral infection routes. As a natural route of transmission, a faeco-oral route was considered [7]. However, the low prevalence of PaBV infections in parrot flocks raised doubts, and Heckmann et al. [8] excluded oral and nasal inoculation as a potent infection route, which was also supported by another study [9]. Later, they demonstrated that PaBVs can probably be transmitted through wounds [10], which was supported by another study proving viral spread along peripheral nerves [11]. Apart from horizontal transmission, vertical transmission of PaBVs is discussed, as PaBV RNA was detected in 2 out of 30 embryos in one study [12]. Monaco et al. [13] demonstrated PaBV RNA in embryos of PaBV-positive parents in 10 of 61 eggs. Virus isolation was not performed. In another study, fertilized eggs of four sun conures were examined and PaBV RNA found in all eggs at the beginning of development. In late-stage embryos, PaBV was also detected in the liver, brain and eyes of the embryos. Surprisingly, after hatching, only a few chicks shed PaBV-RNA. Virus isolation was also not performed [14].
To examine vertical transmission, cockatiel embryos were inoculated with PaBV-2 or PaBV-4 [15]. Inoculation was undertaken in the yolk sac or on the chorioallantoic membrane between days 3 and 5 of egg incubation and the embryo harvested at day 17 of incubation. Depending on the route of inoculation and the virus isolate, between 90% and 100% of the embryos demonstrated PaBV-4 and PaBV-2 RNA and PaBV-4 and PaBV-2 antigens in the brain only. However, virus isolation failed. All these studies point towards vertical transmission as an option for the spread of PaBVs. However, an abortive infection may also occur and prevent vertical transmission. Last but not least, inoculation of embryonated eggs does not correspond to the natural route of infection. Additionally, a previous study demonstrated that the age of a bird at time of infection with PaBV-4 plays a role in the development of the disease and, most likely, in the epizootiology of the infection. This may depend on the full development of the immune system at time of infection [16] and may play a role in vertical transmission. Gartner et al. [16] inoculated cockatiels with PaBV-4 either in the first week after hatching or as adults. Both age groups were raised to sexual maturity and allowed to lay eggs, which served as samples for the present study. Eleven adult cockatiels and eleven cockatiels at the age of 1–6 days were inoculated intravenously with PaBV-4. Afterwards, the birds were monitored for 233 days and the course of infection was documented from the shedding of RNA (RT-PCR) and through determination of PaBV-4 antibodies by IIFA. All 22 cockatiels excreted PaBV-4 RNA and seroconverted during the experimental period. The juvenile birds demonstrated earlier RNA excretion and seroconversion than the adults. Among the adults, 9 of 11 birds exhibited clinical signs of PDD, and only one of the juvenile birds sickened and died but not as a result of PaBV infection. All others remained clinically healthy. In necropsy, 7 of 11 adult birds showed PDD compared to none in the juvenile group. The results provide strong evidence that the age of the cockatiels at the time of infection plays an important role in the expression of clinical signs [16]. The juvenile birds were not yet immunocompetent at hatching, but immunotolerance was not developed. It could be assumed that an earlier infection (such as after vertical infection) would show even larger differences compared to adult infected birds. However, it remains unclear if the findings of Gartner et al. [16] also show an effect on virus transmission routes; in particular, vertical transmission.
Therefore, the laid eggs of the adult and juvenile infected cockatiels (after sexual maturity) from the study by Gartner et al. [16] were investigated to explore the occurrence of PaBV and anti-PaBV antibodies in the embryos and yolk at day 17 of incubation and, especially, to evaluate the influence of the age of the parent bird at time of infection on vertical transmission.
2. Materials and Methods
Parent cockatiels: The cockatiels that laid the eggs for this study were already part of another study [16]. The cockatiels came from an SPF flock that tested negatively for various pathogens, including paramyxovirus-1, psittacine herpesvirus, Chlamydia psittaci and PaBV. Five adult pairs and one single female were kept in cages (162.5 × 50 × 50 cm) with two nesting boxes outside. The ages of the birds were between 405 and 2142 days. Food and water cups were accessible from outside so that the breeding pairs were not disturbed. Additionally, UV light-bulbs and additional protein-rich semi-ripe millet were provided. The pairs were synchronized in breeding and, when 11 cockatiel chicks between 1 and 6 days of age were present, the 11 adult birds and the 11 chicks were inoculated intravenously with a PaBV-4 isolate at the same time. For inoculation, the PaBV-4 isolate Ps34 originated from the brain material of a scarlet macaw (Ara macao). The virus isolate had been used in previous studies [6,8,16].
The juveniles were named J1 to J11, whereas the adult pairs were named A to E, with 1.0 for males and 0.1 for females (Table 1).
After weaning, the juvenile cockatiels were separated from the adult birds. The juveniles were kept either in pairs or in groups of four birds in similar cages as the adults. One cage had a group of four birds consisting of one male (J5) and three females (J3, J4 and J7). The male J5 was mated to all three female birds (J3, J4 and J7). Therefore, they were referred to as Pair 1 (J3/J5), Pair 2 (J4/J5) and Pair 3 (J7/J5). In another cage, the two birds of Pair 4 (J11/J10) were kept together (Table 2).
Both age groups were allowed to lay eggs; the juvenile group started later, after becoming sexually mature.
To achieve a better understanding, the birds infected as chicks were called “juveniles” during the whole study. During the study, a total of 92 eggs were laid. The cockatiels infected as adults laid 49 eggs, whereas the birds infected as juveniles laid 43 eggs. D0.1 of the adult group and J1, J2, J6, J8 and J9 of the juvenile group were not breeding during the time of the study.
Experimental design: All eggs were collected and incubated at 37.4 °C and 60% humidity (HEKA-Format Brutmaschine, HEKA-Brutgeräte–Christa Hemel, Rietberg). After 17 days of incubation, the fertilized eggs were snap frozen for 10 min. Unfertilized eggs were opened and egg yolk and egg white were collected. The embryos of the fertilized eggs were decapitated and the pooled organs (liver, kidneys, gastrointestinal tract, heart), brain, retina and yolk were sampled for further examination by real-time RT-PCR to detect PaBV-4 RNA. Tissue from the brain, retina, pooled organs (liver, kidney, heart and gastrointestinal tract) and yolk were used for virus isolation in an infectivity assay. Embryos that died during incubation were examined as total bodies, if there was not enough material for necropsy, using PCR and virus isolation.
Egg yolk of unfertilized eggs was tested for PaBV-4 RNA, infectious virus and anti-PaBV antibodies, respectively.
PaBV-specific real time RT-PCR: To extract RNA from the samples, the RNeasy Mini Kit (Qiagen, Hilden, Germany) was used according to the manufacturer’s instructions. Afterwards, the RNA of each sample was transcribed by random hexamer primers (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. A Rotor-Gene Q cycler (Qiagen, Hilden, Germany) was used to perform the real-time RT-PCR. The real-time RT-PCR was prepared following Honkavuori et al. [2] using the primer 1034–1322.
Virus isolation: For virus isolation, an infectivity assay was performed as described previously [17]. Briefly, tissue samples and yolk were collected in Gibco TM Glasgow Minimum Essential Medium (Thermo Fisher Scientific, Walthem, MA, USA) with 2% fetal bovine serum. Tissues were suspended in medium (10%, wt/vol) and yolk (50%, wt/vol), sonicated, clarified by centrifugation (1000× g for 10 min) and incubated with CEC-32 cells for six days at 37 °C. Virus replication was visualized with an indirect immunofluorescence assay (IIFA) using a polyclonal serum from experimentally BoDV-infected rats [18].
Serology: Egg yolk samples were tested using an indirect immunofluorescence assay (IIFA) for antibodies against PaBVs as previously described [18]. Yolk samples were diluted 1:2 in PBS def., frozen once and clarified by centrifugation (2000× g for 5 min). The supernatant was tested for antibodies against PaBVs. Briefly, the supernatant of the yolk samples was incubated on slides with acetone-fixed CEC-32 cells persistently infected with the PaBV isolate Ps34. After incubation for 30 min, cells were exposed for 30 min to fluorescein isothiocyanate (FITC)-conjugated goat anti-bird IgG (Bethyl Lab., Inc. Montgomery, TX, USA). Yolk samples were diluted twofold and titrated to the end point [18].
3. Results
3.1. Eggs
During the time of observation (233 days), 92 eggs were laid in total. The adult group laid 49 eggs, with 31 being fertilized and 18 unfertile (Table 3). The first egg was laid 38 days after infection.
In the juvenile group, 43 eggs were laid, 28 of which were fertilized and 15 unfertilized (Table 4). Here, the first egg was laid 160 days after inoculation, as the cockatiels had to mature first. The females of both groups started shedding PaBV-4 RNA consistently via the cloaca prior to the first egg being laid.
Pair 1 (A0.1/A1.0) only laid one egg because the female bird (A0.1) died early during the study with unspecific symptoms, such as weight loss and apathy. Pair 2 (B0.1/B1.0) laid four eggs. Three of them were fertilized. Pair 3 (C0.1/C1.0) laid 31 eggs in total: 27 were fertilized and 4 were unfertilized. Pair 4 (E0.1/D1.0) had ten unfertilized eggs. Pair 5 (F0.1/E1.0) laid three eggs, also all unfertilized.
In the juvenile group, the four birds J3, J4, J5 and J7 were held together. The male bird J5 was breeding with three different females (J3, J4 and J7). Therefore, they were designated Pair 1 (J3/J5), Pair 2 (J4/J5) and Pair 3 (J7/J5). There were two nesting boxes per cage. Pair 1 (J3/J5) was breeding in the same nesting box with another female (Pair 2: J4/J5). The female bird J4 started laying eggs first, so a few eggs could be identified as hers. After a few days, female bird J3 also started laying eggs in the same nesting box. Therefore, the eggs could no longer be kept apart and were named J3/4. The male bird of Pairs 1 and 2 also fertilized eggs with another bird (Pair 3: J7/J5), which could be kept separate from the eggs of Pairs 1 and 2 because they had a separate nest in the other nesting box of the cage. Pair 4 consisted of two birds (J11/J10) that were kept in a separate cage. Pairs 1 and 2 laid 31 eggs together: 18 fertilized and 13 unfertilized. Ten embryos were dead before reaching day 17 in the incubator. Pair 2 laid three eggs that could be kept apart: one was fertilized, two were unfertilized. Pair 3 laid one fertilized egg which was the only egg that was laid in total. This one embryo was dead before day 17. Pair 4 laid eight fertilized eggs, and all embryos survived until day 17.
3.2. PCR
3.2.1. Embryos
Adult group: In 15/31 (48%) of the embryos (Appendix A), PaBV-4 RNA was detected. The one fertile egg of Pair 1 (A0.1/A1.0) and all fertile eggs of Pair 2 (B0.1/B1.0) were negative in the PaBV-specific RT-PCR. In Pair 3, 15 of 27 (56%) embryos were positive in the PaBV-specific RT-PCR, the first being positive 141 days after infection of the female parent. Pairs 4 and 5 did not have any fertile eggs.
Juvenile group: In the juvenile group, 25/28 (89.3%) embryos (Appendix B) were positive in the PaBV-specific RT-PCR, and 16/18 (89%) embryos of Pairs 1 and 2 were positive in the PCR. The embryo of Pair 3 was also positive in the PCR (1/1, 100%). All fertile eggs (8/8, 100%) of Pair 4 were positive in the PCR.
3.2.2. Egg Yolk
Adult group: In 20/39 (51%) egg yolks in the adult group, PaBV-4 RNA was detected, and 18/22 (82%) egg yolks of Pair 3 and 2/10 (20%) of Pair 4 were positive in the PaBV-4 PCR. All three eggs of Pair 5 in the adult group were negative for the detection of PaBV-4 RNA.
Juvenile group: In the juvenile group, 27/27 (100%) egg yolks tested positive for PaBV-4 RNA. All 23/23 (100%) of the yolks of Pairs 1 and 2 of the juvenile group were positive in the PCR. The yolk of the one egg of Pair 3 was not examined by PaBV-4 PCR. All egg yolks of Pair 4 (4/4, 100%) tested positive for PaBV-4 RNA.
3.3. Virus Isolation
3.3.1. Embryos
Adult group: In the adult group, virus isolation failed in all 31 embryos of the different pairs (Table 3 and Figure 1c).
Juvenile group: In the juvenile group, PaBV-4 was isolated from 9/21 (42.9%) embryos. PaBV-4 was isolated from 6/15 (40%) of the embryos from Pairs 1 and 2, 1/1 (100%) from Pair 3 and 2/5 (40%) from Pair 4. Virus isolation was also possible in the dead embryos of Pairs 1 and 2 in five out of six embryos (83%) and in the only embryo (100%) of Pair 3. Pair 4 had no dead embryos (Table 4 and Figure 1e,f).
3.3.2. Yolk
Adult group: In the adult group, 6/37 (16%) egg yolks were positive in the infectivity assay, all of them originating from the fertilized eggs of Pair 3 (Table 3 and Figure 1d). PaBV-4 isolation was not performed for the yolks of Pair 1 and only in one yolk of Pair 2. With Pair 4 (ten yolks) and Pair 5 (three yolks), virus isolation failed. All those yolks came from unfertilized eggs because Pairs 4 and 5 did not have any fertilized eggs. The virus was only isolated in cases where the yolk was also positive for PaBV PCR with ct values below 30.
Juvenile group: In the juvenile group, PaBV-4 isolation was possible in 11/27 (41%) egg yolks of fertilized eggs (Table 4, Figure 1a,b). In detail, for Pair 1 and Pair 2 of the juvenile group, PaBV-4 was isolated in six out of seven (86%) of egg yolks from the fertilized eggs. One yolk was toxic for the cells and, therefore, no result was obtained. The virus could also be isolated from the only (100%) yolk from Pair 2 and from four out of five (80%) yolks of Pair 3. The yolk of one fertilized egg from Pair 4 was not examined in the infectivity assay. The unfertilized eggs in the juvenile group (12/12) were all negative in the PaBV-4 isolation.
3.4. Serology
In 45 of 49 (92%) of the egg yolks (from fertilized and unfertilized eggs) of the adult group, anti-PaBV antibodies were detected. The antibody titers ranged from 640 to 5120. The four negative eggs originated from birds A0.1 and B0.1 and were laid before seroconvertion of the female parent (Figure 2a).
In all 43 egg yolks (from fertilized and unfertilized eggs) in the juvenile group, anti-PaBV antibodies were detected with antibody titers comparable to the adult group (Figure 2b,c).
4. Discussion
The aim of the study was to investigate the possibility of vertical transmission of PaBV-4 in parrots with regard to the age at time of infection of the parent birds. For the first time, vertical transmission was demonstrated, but there were differences in the prevalence of PaBV-4-positive eggs and the isolation of the infectious virus with regard to the age when the parent birds were infected with PaBV-4. Vertical transmission occurred from parent birds that were infected as nestlings and the infectious virus could only be detected in embryos under this condition. In birds infected as adults, the infectious virus was not found in embryos but only in the yolks of a low number of eggs laid from just one bird. However, PaBV-4 RNA was also detected from embryos of the adult group.
In the adult group, isolation of PaBV-4 was only possible in 6/37 yolks of Pair 3. Interestingly, the female parent of these eggs was the youngest (405 days) in the adult group at the time of infection. It was also noticeable that this bird developed no clinical symptoms and showed no dilatation of the proventriculus after infection with PaBV-4 [16], which was comparable to the birds infected as juveniles. However, it remains unclear if the detection of PaBV-4 RNA in the embryos of the adult group was for an abortive infection or also a valid vertical transmission but with a viral load too low for virus isolation, as was also speculated by Wüst et al. [15]. Further studies must be carried out in order to evaluate this and determine whether the potential immunotolerance of the birds supports vertical transmission or not.
In the adult group, 48% of the embryos were positive in the PaBV-4-specific RT-PCR, while the juvenile group had more than 89% positive embryos in the PaBV-specific PCR. Interestingly, all embryos of the adult group survived until they were harvested, while 8/19 embryos of the juvenile group died during incubation. These dead embryos originated from female birds that had been infected four days after hatching. PaBV-4 was isolated from four out of five dead embryos. In contrast, all eight embryos of a female bird infected one day after hatching were alive. For this bird, PaBV-4 was isolated from two out of five embryos and four out of five yolks. However, individual effects of pairing leading to embryonic death cannot be excluded. Therefore, it cannot be speculated whether the death of the embryo was triggered by PaBV-4. As none of the parent birds that were infected as juveniles during their first week of life demonstrated any clinical signs, it seems unlikely that embryos infected vertically develop clinical disease. It seems more likely that vertical transmission creates carrier birds comparable to those infected during the first week of life. This might be due to the immune incompetence at the time of infection, as PaBV-4 infections trigger an immune-mediated clinical disease [19]. However, this theory needs to be further evaluated and proven.
Interestingly, the parent birds of both groups shed PaBV-4 RNA at the time that they laid the first eggs. Therefore, shedding of PaBV-4 RNA seems not to be correlated with vertical transmission and isolation of infectious virus from the embryos. However, the amount of PaBV-4 virus shed at the time of egg laying, as well as the tissue distribution of PaBV-4 during egg laying in individual birds, might be factors influencing vertical transmission; this was not investigated in this study but might be a focus in the future. However, as the differences between the two groups were not high [16], this does not seem likely. Additionally, the presence of anti-PaBV antibodies in the serum of the parent birds, as well as in the yolk of the eggs, did not seem to affect transmission. After seroconversion of the female parent, antibodies were detected in nearly all egg yolks examined. Only two females of the adult group (the oldest female birds) laid four eggs before seroconversion. As expected, no antibodies were detectable in those yolks. In the juvenile group, the antibodies in the yolk had no effect on virus replication in the embryos and did not protect the embryos from infection. To date, no neutralizing antibodies against PaBV have been described [20].
It should be considered that the time between infection of the parent bird and the start of egg laying varied between the groups, and this could have been another reason for the detected differences in vertical transmission rather than the age of the parent bird at time of infection. The juvenile group laid their eggs after sexual maturity, while the adults laid eggs right at the beginning and throughout the complete experimental period. The first egg of the juvenile group was laid 160 days after infection. From day 167 p.i., the first positive virus isolations of the egg yolk and positive PCR results were obtained in this group. Positive virus isolations from the embryos occurred from day 208 p.i. onwards. The eggs of the adult group were already being examined up to day 160 p.i., as well as later, and they were comparable after day 208 p.i. Here too, no positive virus isolation was detected from the embryos. However, the numbers of fertilized eggs in the adult group after 160 days p.i. were limited, and it cannot be excluded that single eggs would have been positive in virus isolation after this time point. Nevertheless, it seems unlikely that the time after infection was the main reason for the differences between the groups. Adults and juveniles started shedding PaBV from 31 days p.i. onwards in similar amounts but, in the adult group, the embryos did not test positive in the infectivity assay at any time. In addition, the differences between the two groups in the occurrence of PaBV-RNA and life virus in the yolk and embryos were also very high for infertile eggs, which were also laid in the adult group after 160 dpi in considerable numbers. Furthermore, the virus was already detected in the yolk of infertile eggs at day 141 in the adult group. Lastly, both juvenile and adult parents tested positive for PaBV-4 in all organs [16], which makes a difference in transmission due to the time span between infection and egg laying unlikely. Therefore, it seems appropriate to assume that the age of the bird at the time of infection played a larger role in the detected differences, as the epizootiology also varied between those two groups [16]. However, this should be clarified in future studies involving a larger amount of parent birds infected at different times and with the collection of more eggs at later time points.
Detection of infectious PaBV-4 in embryos of parent birds infected shortly after hatching confirms vertical transmission for the first time. This transmission route may be responsible for the creation of carrier birds and the maintenance of PaBV-4 in the psittacine population. Those birds could potentially infect other birds through horizontal transmission through wounds [10], and birds infected in this way might develop disease, as previously shown [16]. Knowing that vertical transmission is possible, control strategies in flocks can be developed to prevent further infections. Additionally, it is possible that not all eggs of PaBV-4-infected parents were infected by vertical transmission (9/31 (29%) of the eggs from the adult group were negative in the PaBV-specific PCR and virus isolation and none from the juvenile group), although there could also have been too small an amount of the virus, insufficient for detection. In species conservation breeding programs, this information is highly important, as PaBV-infected rare parent birds might still be used as breeders since it seems to be possible to obtain negative offspring from them, which has already been speculated before [3] and also demonstrated in canary birds [21].
With this study, better control over PaBV infections should be possible in the future in addition to better management of breeding flocks. It seems that controlling vertical transmission might control the spread of the disease.
Author Contributions
Writing—original draft: J.L. and M.L.; writing—review and editing: S.H. and A.M.G.; conceptualization and supervision: M.L. and S.H.; methodology: J.L., A.M.G., B.B., M.K., S.H. and M.L.; investigation: J.L. and S.H. All authors have read and agreed to the published version of the manuscript.
Funding
This research received no external funding.
Institutional Review Board Statement
Embryonated eggs investigated in this study originated from an animal trial approved by the government RP Giessen, no. 18/9 36/2015. The investigation of the eggs in the study was performed before hatching and the embryos were euthanized with an appropriated method. No ethical approval was necessary according to the German Animal Welfare Act (Tierschutzgesetz and Tierschutz-Versuchstierverordnung §14 Abs. 2).
Data Availability Statement
Not applicable.
Conflicts of Interest
The authors declare no conflict of interest.
Appendix A
Table A1.
Results of PaBV-specific PCR in embryo brains and egg yolk and results of virus isolation from embryo and egg yolk in the adult infected group sorted by egg number; “+” means the egg was fertilized, “−“ means the egg was unfertilized. A0.1 seroconverted at 36 dpi with a titer of 1:640, B0.1 seroconverted at 57 dpi with 1:320, C0.1 seroconverted at dpi 71 with 1:320, E0.1 seroconverted at 36 dpi with 1:160, F0.1 seroconverted at day 57 with 1:1280.
Table A1.
Results of PaBV-specific PCR in embryo brains and egg yolk and results of virus isolation from embryo and egg yolk in the adult infected group sorted by egg number; “+” means the egg was fertilized, “−“ means the egg was unfertilized. A0.1 seroconverted at 36 dpi with a titer of 1:640, B0.1 seroconverted at 57 dpi with 1:320, C0.1 seroconverted at dpi 71 with 1:320, E0.1 seroconverted at 36 dpi with 1:160, F0.1 seroconverted at day 57 with 1:1280.
| Bird/Egg No. | Egg Laid dpi | Egg Laid Days Post-Seroconversion | Anti-PaBV Titer of Egg Yolk | Fertilized | Virus Isolation Brain/Embryo | Virus Isolation Egg Yolk | PaBV PCR of Brain/ct Value | PaBV PCR of Yolk/ct Value |
|---|---|---|---|---|---|---|---|---|
| A0.1 1 | 38 | 2 | <10 | + | Negative | Not performed | Negative/− | Negative/− |
| B0.1 2 | 52 | −5 | <10 | + | Negative | Not performed | Negative/− | Negative/− |
| 3 | 54 | −3 | <10 | + | Negative | Not performed | Negative/− | Negative/− |
| 4 | 56 | −1 | <10 | + | Negative | Not performed | Negative/− | Negative/− |
| 5 | 71 | 14 | 640 | − | N/A | Negative | N/A | Not performed |
| C0.1 6 | 106 | 35 | 2560 | + | Negative | Not performed | Negative/− | Positive/35.27 |
| 7 | 107 | 36 | 2560 | + | Negative | Negative | Negative/− | Not performed |
| 8 | 109 | 38 | 2560 | + | Negative | Not performed | Negative/− | Positive/36.59 |
| 10 | 111 | 40 | 2560 | + | Negative | Negative | Negative/− | Negative/− |
| 11 | 113 | 42 | 2560 | + | Negative | Negative | Negative/− | Positive/38.23 |
| 12 | 122 | 51 | 1280 | + | Negative | Negative | Negative/− | Positive/37.08 |
| 13 | 123 | 52 | 1280 | + | Negative | Negative | Negative/− | Negative/− |
| 14 | 129 | 2560 | −, shrivelled | N/A | Negative | N/A | Not performed | |
| 15 | 125 | 54 | 2560 | + | Negative | Negative | Negative/− | Negative/− |
| 16 | 126 | 55 | 5120 | + | Negative | Negative | Negative/− | Negative/43.46 |
| 19 | 141 | 70 | 2560 | + | Negative | Negative | Positive/35.43 | Positive/36.19 |
| 20 | 143 | 72 | 2560 | + | Negative | Negative | Negative/− | Positive/37.19 |
| 21 | 145 | 74 | 1280 | + | Negative | Negative | Negative/− | Positive/33.34 |
| 23 | 147 | 76 | 2560 | + | Negative | Negative | Negative/− | Positive/30.69 |
| 27 | 159 | 88 | 1280 | + | Negative | Positive | Positive/33.55 | Not performed |
| 28 | 161 | 90 | 5120 | + | Negative | Negative | Positive/37.53 | Positive/27.38 |
| 29 | 163 | 92 | 5120 | + | Negative | Positive | Positive/35.90 | Positive/27.10 |
| 34 | 165 | 94 | 5120 | + | Negative | Positive | Positive/36.63 | Positive/26.97 |
| 42 | 180 | 109 | 5120 | + | Negative | Positive | Positive/35.29 | Positive/28.19 |
| 44 | 182 | 111 | 1280 | + | Negative | Positive | Positive/34.44 | Positive/26.70 |
| 47 | 184 | 113 | 1280 | + | Negative | Negative | Positive/31.36 | Positive/26.24 |
| 50 | 186 | 115 | 1280 | + | Negative | Negative | Positive/32.28 | Positive/30.08 |
| 53 | 189 | 118 | 2560 | + | Negative | Positive | Positive/34.67 | Positive/25.42 |
| 61 | 202 | 131 | 5120 | + | Negative | Not performed | Dead embryo positive/ | Not performed |
| 63 | 204 | 133 | 2560 | + | Negative | Not performed | Positive/36.94 | Not performed |
| 65 | 206 | 135 | 2560 | + | Negative | Negative | Positive/33.71 | Positive/25.66 |
| 68 | 208 | 137 | 2560 | + | Negative | Not performed | Positive/31.53 | Not performed |
| 69 | 210 | 139 | 2560 | + | Negative | Not performed | Positive/30.69 | Not performed |
| 71 | 212 | 141 | 5120 | − | N/A | Negative | N/A | Positive/28.57 |
| 85 | 227 | 156 | 2560 | − | N/A | Not performed | N/A | Not performed |
| 89 | 229 | 158 | 2560 | − | N/A | Not performed | N/A | Not performed |
| E0.1 9 | 111 | 75 | 2560 | − | N/A | Negative | N/A | Negative/− |
| 17 | 140 | 104 | 2560 | − | N/A | Negative | N/A | Negative/− |
| 18 | 141 | 105 | 5120 | − | N/A | Negative | N/A | Positive/33.71 |
| 22 | 143 | 107 | 2560 | − | N/A | Negative | N/A | Negative/− |
| 46 | 183 | 147 | 2560 | − | N/A | Negative | N/A | Negative/44.26 |
| 48 | 185 | 149 | 2560 | − | N/A | Negative | N/A | Negative/44.18 |
| 51 | 187 | 151 | 1280 | − | N/A | Negative | N/A | Negative/− |
| 78 | 218 | 182 | 5120 | − | N/A | Negative | N/A | Negative/− |
| 79 | 219 | 183 | 5120 | − | N/A | Negative | N/A | Positive/33.46 |
| 82 | 221 | 185 | 5120 | − | N/A | Negative | N/A | Negative/− |
| F0.1 24 | 156 | 99 | 5120 | − | N/A | Negative | N/A | Negative/− |
| 25 | 158 | 101 | 2560 | − | N/A | Negative | N/A | Negative/− |
| 26 | 160 | 103 | 2560 | − | N/A | Negative | N/A | Negative/− |
Appendix B
Table A2.
Results of PaBV-specific PCR in embryo brains and egg yolk and results of virus isolation from embryo and egg yolk in the adult infected group sorted by egg number; “+” means the egg was fertilized, “−“ means the egg was unfertilized. Eggs with the same dpi were laid on the same day in one nest (in nos. 86 and 90, the brain could be examined separately despite the embryo dying until day 17 in the incubator).
Table A2.
Results of PaBV-specific PCR in embryo brains and egg yolk and results of virus isolation from embryo and egg yolk in the adult infected group sorted by egg number; “+” means the egg was fertilized, “−“ means the egg was unfertilized. Eggs with the same dpi were laid on the same day in one nest (in nos. 86 and 90, the brain could be examined separately despite the embryo dying until day 17 in the incubator).
| Bird/Egg No. | Egg Laid dpi | Egg Laid Days Post-Seroconversion | Anti-PaBV Titer of Egg Yolk | Fertilized | Virus Isolation Brain/Embryo | Virus Isolation Egg Yolk | PaBV PCR of Brain/ct Value | PaBV PCR of Yolk/ct Value |
|---|---|---|---|---|---|---|---|---|
| J3/4 32 | 164 | N/A | 160 | − | N/A | Negative | N/A | Positive/29.87 |
| 33 | 164 | N/A | 2560 | − | N/A | Negative | N/A | Positive/35.85 |
| 35 | 166 | N/A | 2560 | − | N/A | Negative | N/A | Positive/34.91 |
| 36 | 167 | N/A | 1280 | + | Negative | Positive | Positive/36.84 | Positive/30.66 |
| 37 | 167 | N/A | 640 | + | Negative | Positive | Positive/36.89 | Positive/31.38 |
| 38 | 169 | N/A | 640 | + | Not performed | Negative | Positive/embryo 33.68 | Positive/32.37 |
| 40 | 178 | N/A | 320 | + | Negative | Toxic | Negative/− | Positive/30.25 |
| 41 | 179 | N/A | 640 | + | Negative | Positive | Negative/− | Positive/25.67 |
| 43 | 181 | N/A | 2560 | + | Negative | Positive | Positive/33.56 | Positive/28.28 |
| 45 | 183 | N/A | 1280 | + | Not performed | Positive | Positive/embryo 29.77 | Positive/28.13 |
| 49 | 185 | N/A | 2560 | + | Not performed | Positive | Positive/embryo 30.92 | Positive/28.21 |
| 55 | 192 | N/A | 640 | − | N/A | Negative | N/A | Positive/26.27 |
| 58 | 194 | N/A | 1280 | − | N/A | Negative | N/A | Positive/31.87 |
| 59 | 197 | N/A | 1280 | − | N/A | Negative | N/A | Positive/29.12 |
| 60 | 201 | N/A | 1280 | − | N/A | Negative | N/A | Positive/30.85 |
| 62 | 203 | N/A | 1280 | − | N/A | Negative | N/A | Positive/30.41 |
| 64 | 206 | N/A | 1280 | − | N/A | Negative | N/A | Positive/32.62 |
| 66 | 208 | N/A | 1280 | + | Negative | Not performed | Negative/− | Not performed |
| 67 | 208 | N/A | 1280 | + | Positive | Not performed | Positive (embryo)/31.08 | Not performed |
| 70 | 210 | N/A | 2560 | + | Negative | Not performed | Positive (embryo)/28.56 | Not performed |
| 73 | 215 | N/A | 1280 | + | Negative | Not performed | Positive/33.94 | Not performed |
| 75 | 216 | N/A | 2560 | + | Positive | Not performed | Positive/28.77 | Not performed |
| 77 | 218 | N/A | 2560 | + | Positive | Not performed | Positive (embryo)/25.62 | Not performed |
| 83 | 221 | N/A | 1280 | + | Not performed | Not performed | N/A | Not performed |
| 84 | 225 | N/A | 1280 | − | N/A | Negative | N/A | Positive/31.14 |
| 86 | 227 | N/A | 2560 | + | Positive | Not performed | Positive/38.02 | Not performed |
| 87 | 227 | N/A | 2560 | − | N/A | Negative | N/A | Positive/31.87 |
| 88 | 228 | N/A | 1280 | − | N/A | Negative | N/A | Positive/29.49 |
| 90 | 229 | N/A | 2560 | + | Positive | Not performed | Positive/29.90 | Not performed |
| 91 | 231 | N/A | 2560 | + | Positive | Not performed | Positive/31.64 | Not performed |
| 92 | 232 | N/A | 2560 | + | Negative | Not performed | Positive/31.86 | Not performed |
| J4 30 | 160 | 117 | 5120 | − | N/A | Negative | N/A | Positive/35.07 |
| 31 | 161 | 118 | 5120 | − | N/A | Negative | N/A | Positive/31.64 |
| 39 | 171 | 128 | 640 | + | Negative | Positive | Positive/34.20 | Positive/27.69 |
| J7 80 | 220 | 184 | 2560 | + | Positive | Not performed | Positive (embryo)/31.29 | Not performed |
| J11 52 | 189 | 153 | 1280 | + | Not performed | Positive | Positive/24.24 | Positive/25.62 |
| 54 | 191 | 141 | 640 | + | Not performed | Positive | Positive/32.51 | Positive/25.08 |
| 56 | 193 | 143 | 640 | + | Not performed | Positive | Positive/32.04 | Positive/20.87 |
| 57 | 194 | 144 | 640 | + | Negative | Positive | Positive/32.36 | Positive/25.60 |
| 72 | 214 | 164 | 1280 | + | Negative | Not performed | Positive/32.94 | Not performed |
| 74 | 216 | 166 | 2560 | + | Negative | Not performed | Positive/31.02 | Not performed |
| 76 | 218 | 168 | 1280 | + | Positive | Not performed | Positive/30.11 | Not performed |
| 81 | 220 | 170 | 1280 | + | Positive | Negative | Positive/28.26 | Not performed |
References
- Kistler, A.L.; Gancz, A.; Clubb, S. Recovery of divergent avian bornaviruses from cases of proventricular dilatation disease: Identification of a candidate etiologic agent. Virol. J. 2008, 5, 88. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Honkavuori, K.S.; Shivaprasad, H.L.; Williams, B.L.; Quan, P.L.; Hornig, M.; Street, C. Novel Borna virus in psittacine birds with proventricular dilatation disease. Emerg. Infect. Dis. 2008, 14, 1883–1886. [Google Scholar] [CrossRef] [PubMed]
- Lierz, M. Avian Bornavirus and Proventricular Dilatation Disease. In Current Therapy in Avian Medicine and Surgery, 1st ed.; Speer, B., Ed.; Elsevier: St. Louis, MI, USA, 2016; pp. 28–46. [Google Scholar]
- Gancz, A.Y.; Kistler, A.L.; Greninger, A.L.; Farnoushi, Y.; Mechani, S.; Perl, S. Experimental induction of proventricular dilatation disease in cockatiels (Nymphicus hollandicus) inoculated with brain homogenates containing avian bornavirus 4. Virol. J. 2009, 6, 100. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gray, P.; Hoppes, S.; Suchodolski, P.; Mirhosseini, N.; Payne, S.; Villanueva, I. Use of Avian Bornavirus Isolates to Induce Proventricular Dilatation Disease in Conures. Emerg. Infect. Dis. 2010, 16, 473–479. [Google Scholar] [CrossRef] [PubMed]
- Piepenbring, A.K.; Enderlein, D.; Herzog, S.; Kaleta, E.F.; Heffels-Redmann, U.; Ressmeyer, S. Pathogenesis of Avian Bornavirus in Experimentally Infected Cockatiels. Emerg. Infect. Dis. 2012, 18, 234–241. [Google Scholar] [CrossRef] [PubMed]
- Rubbenstroth, D.; Schmidt, V.; Rinder, M.; Legler, M.; Twietmeyer, S. Phylogenetic Analysis Supports Horizontal Transmission as a Driving Force of the Spread of Avian Bornaviruses. PLoS ONE 2016, 11, e0160936. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Heckmann, J.; Enderlein, D.; Piepenbring, A.K.; Herzog, S.; Heffels-Redmann, U.; Malberg, S.; Herden, C.; Lierz, M. Investigation of Different Infection Routes of Parrot Bornavirus in Cockatiels. Avian Dis. 2017, 61, 90–95. [Google Scholar] [CrossRef] [PubMed]
- Runge, S.; Olbert, M.; Herden, C.; Malberg, S.; Römer-Oberdörfer, A.; Staeheli, P.; Rubbenstroth, D. Viral vector vaccines protect cockatiels from inflammatory lesions after heterologous parrot bornavirus 2 challenge infection. Vaccine 2017, 35, 557–563. [Google Scholar] [CrossRef] [PubMed]
- Heckmann, J.; Enderlein, D.; Gartner, A.M.; Bücking, B.; Herzog, S.; Heffels-Redmann, U.; Malberg, S.; Herden, C.; Lierz, M. Wounds as the Portal of Entrance for Parrot Bornavirus-4 (PaBV-4) and Retrograde Axonal Transport in Experimentally Infected Cockatiels (Nymphicus hollandicus). Avian Dis. 2020, 64, 247–253. [Google Scholar] [CrossRef] [PubMed]
- Leal de Araujo, J.; Rech, R.R.; Heatley, J.J.; Guo, J.; Giaretta, P.R. From nerves to brain to gastrointestinal tract: A time-based study of parrot bornavirus 2 (PaBV-2) pathogenesis in cockatiels (Nymphicus hollandicus). PLoS ONE 2017, 12, e0187797. [Google Scholar] [CrossRef] [PubMed]
- Lierz, M.; Piepenbring, A.; Herden, C.; Oberhäuser, K.; Heffels-Redmann, U.; Enderlein, D. Vertical Transmission of Avian Bornavirus in Psittacines. Emerg. Infect. 2011, 17, 2390–2391. [Google Scholar] [CrossRef] [PubMed]
- Monaco, E.; Hoppes, S.; Guo, J.; Tizard, I. The Detection of Avian Bornavirus Within Psittacine Eggs. J. Avian Med. Surg. 2012, 26, 144–148. [Google Scholar] [CrossRef] [PubMed]
- Kerski, A.; de Kloet, A.H.; de Kloet, S.R. Vertical Transmission of Avian Bornavirus in Psittaciformes: Avian Bornavirus RNA and Anti-Avian Bornavirus Antibodies in Eggs, Embryos, and Hatchlings Obtained from Infected Sun Conures (Aratinga solstitialis). Avian Dis. 2012, 56, 471–478. [Google Scholar] [CrossRef] [PubMed]
- Wüst, E.; Malberg, S.; Petzold, J.; Enderlein, D.; Heffels-Redmann, U.; Herzog, S.; Herden, C.; Lierz, M. Experimental Infection of Embryonic Cells and Embryonated Eggs of Cockatiels (Nymphicus hollandicus) With Two Parrot Bornavirus Isolates (PaBV-4 and PaBV-2). Viruses 2022, in press.
- Gartner, A.M.; Link, J.; Bücking, B.; Enderlein, D.; Herzog, S.; Petzold, J.; Malberg, S.; Herden, C.; Lierz, M. Age-dependent development and clinical characteristics of an experimental parrot bornavirus-4 (PaBV-4) infection in cockatiels (Nymphicus hollandicus). Avian Pathol. 2021, 50, 138–150. [Google Scholar] [CrossRef] [PubMed]
- Narayan, O.; Herzog, S.; Frese, K.; Scheefers, H.; Rott, R. Behavioral Disease in Rats Caused by Immunopathological Responses to Persistent Borna Virus in the Brain. Science 1983, 220, 1401–1403. [Google Scholar] [CrossRef] [PubMed]
- Herzog, S.; Enderlein, D.; Heffels-Redmann, U.; Piepenbring, A.K.; Neumann, D.; Kaleta, E.F. Indirect Immunofluorescence Assay for Intra Vitam Diagnosis of Avian Bornavirus Infection in Psittacine Birds. J. Clin. Microbiol. 2010, 48, 2282–2284. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hameed, S.S.; Guo, J.; Tizard, I.; Shivaprasad, H.L.; Payne, S. Studies on immunity and immunopathogenesis of parrot bornaviral disease in cockatiels. Virology 2018, 515, 81–91. [Google Scholar] [CrossRef] [PubMed]
- De Kloet, S.R.; Dorrestein, G.M. Presence of avian Bornavirus RNA and Anti-Avian Bornavirus Antibodies in Apparently Healthy Macaws. Avian Dis. 2009, 53, 568–573. [Google Scholar] [CrossRef] [PubMed]
- Rubbenstroth, D.; Brosinski, K.; Rinder, M.; Olbert, M.; Kaspers, B.; Korbel, R. No contact transmission of avian bornavirus in experimentally infected cockatiels (Nymphicus hollandicus) and domestic canaries (Serinus canaria forma domestica). Vet. Microbiol. 2014, 172, 146–156. [Google Scholar] [CrossRef] [PubMed]
Figure 1.
(a) Infectivity assay: CEC-32 cell culture with immunofluorescence of PaBV-specific antigen—juvenile group, yolk sample J11/54 (positive), 200× total magnification; (b) infectivity assay: CEC-32 cell culture with immunofluorescence of PaBV-specific antigen—juvenile group, yolk sample J3/4/55 (negative), 200× total magnification; (c) infectivity assay: CEC-32 cell culture with immunofluorescence of PaBV-specific antigen—adult group, embryo C0.1/61 (negative), 200× total magnification; (d) infectivity assay: CEC-32 cell culture with immunofluorescence of PaBV-specific antigen—adult group, yolk sample C0.1/53 (positive), 200× total magnification; (e) infectivity assay: CEC-32 cell culture with immunofluorescence of PaBV-specific antigen—juvenile group, embryo J3/4/77 (positive), 200× total magnification; (f) infectivity assay: CEC-32 cell culture with immunofluorescence of PaBV-specific antigen—juvenile group, brain J11/76 (positive), 200× total magnification.
Figure 1.
(a) Infectivity assay: CEC-32 cell culture with immunofluorescence of PaBV-specific antigen—juvenile group, yolk sample J11/54 (positive), 200× total magnification; (b) infectivity assay: CEC-32 cell culture with immunofluorescence of PaBV-specific antigen—juvenile group, yolk sample J3/4/55 (negative), 200× total magnification; (c) infectivity assay: CEC-32 cell culture with immunofluorescence of PaBV-specific antigen—adult group, embryo C0.1/61 (negative), 200× total magnification; (d) infectivity assay: CEC-32 cell culture with immunofluorescence of PaBV-specific antigen—adult group, yolk sample C0.1/53 (positive), 200× total magnification; (e) infectivity assay: CEC-32 cell culture with immunofluorescence of PaBV-specific antigen—juvenile group, embryo J3/4/77 (positive), 200× total magnification; (f) infectivity assay: CEC-32 cell culture with immunofluorescence of PaBV-specific antigen—juvenile group, brain J11/76 (positive), 200× total magnification.
Figure 2.
(a) No detection of anti-PaBV antibodies from yolk sample B0.1/4 before seroconversion (titer < 1:10) by indirect immunofluorescence assay (IIFA) on CEC-32 cells, 200× total magnification; (b) anti-PaBV antibody detection from yolk sample B0.1/5 after seroconversion (titer 1:640) by indirect immunofluorescence assay (IIFA) on CEC-32 cells, 200× total magnification; (c) anti-PaBV antibody detection from yolk sample J11/81 (titer 1:1280) by indirect immunofluorescence assay (IIFA) on CEC-32 cells, 200× total magnification.
Figure 2.
(a) No detection of anti-PaBV antibodies from yolk sample B0.1/4 before seroconversion (titer < 1:10) by indirect immunofluorescence assay (IIFA) on CEC-32 cells, 200× total magnification; (b) anti-PaBV antibody detection from yolk sample B0.1/5 after seroconversion (titer 1:640) by indirect immunofluorescence assay (IIFA) on CEC-32 cells, 200× total magnification; (c) anti-PaBV antibody detection from yolk sample J11/81 (titer 1:1280) by indirect immunofluorescence assay (IIFA) on CEC-32 cells, 200× total magnification.
Table 1.
PaBV history of the parent birds: 0.1 is female, 1.0 is male.
| First Detection (dpi) | |||||
|---|---|---|---|---|---|
| Group | ID | Sex | Age at Time of Infection in Days/Years | Anti-PaBV Antibodies (Titer) | PaBV RNA |
| A (adult infected) | A0.1 | Female | 1814/4.9 | 36 (1:640) | 36 |
| A1.0 | Male | 2142/5.8 | 57 (1:2560) | 48 | |
| B0.1 | Female | 668/1.8 | 57 (1: 320) | 31 | |
| B1.0 | Male | 2043/5.6 | 57 (1:2560) | 41 | |
| C0.1 | Female | 405/1.2 | 71 (1:320) | 50 | |
| C1.0 | Male | 493/1.4 | 50 (1:80) | 41 | |
| D0.1 | Female | 629/1.7 | 71 (1:1280) | 45 | |
| D1.0 | Male | 665/1.8 | 36 (1:40) | 66 | |
| E0.1 | Female | 422/12 | 36 (1:160) | 55 | |
| E1.0 | Male | 417/1.1 | 71 (1:5120) | 50 | |
| F0.1 | Female | 424/1.2 | 57 (1:1280) | 31 | |
| J (juvenile infected) | J1 | Male | 6 | 50 (1:320) | 36 |
| J2 | Female | 5 | 50 (1:320) | 34 | |
| J3 | Female | 4 | 36 (1:40) | 29 | |
| J4 | Female | 4 | 43 (1:80) | 31 | |
| J5 | Male | 3 | 43 (1:160) | 27 | |
| J6 | Female | 3 | 57 (1:1280) | 27 | |
| J7 | Female | 1 | 36 (1:80) | 34 | |
| J8 | Male | 1 | 99 (1:640) | 52 | |
| J9 | Female | 1 | 36 (1:40) | 27 | |
| J10 | Male | 1 | 43 (1:80) | 29 | |
| J11 | Female | 1 | 50 (1:640) | 34 | |
Table 2.
Pairs of adult and juvenile infected birds. Those marked with * were nesting in a group, and the male J5 had several females.
Table 2.
Pairs of adult and juvenile infected birds. Those marked with * were nesting in a group, and the male J5 had several females.
| Infected as Adults (f/m) | Age at Infection (m/f) in Days | Infected as Juveniles (f/m) | Age at Infection (m/f) in Days |
|---|---|---|---|
| Pair 1 (A0.1/A1.0) | 2142/1814 | Pair 1 (J3/J5 *) | 4/3 |
| Pair 2 (B0.1/B1.0) | 2043/668 | Pair 2 (J4/J5 *) | 4/3 |
| Pair 3 (C0.1/C1.0) | 493/405 | Pair 3 (J7/J5 *) | 1/3 |
| Pair 4 (E0.1/D1.0) | 665/422 | Pair 4 (J11/J10) | 1/1 |
| Pair 5 (F0.1/E1.0) | 417/424 |
Table 3.
Adult infected cockatiels: vertical transmission. Not all embryos were examined in all tests due to technical reasons. NP: not performed.
Table 3.
Adult infected cockatiels: vertical transmission. Not all embryos were examined in all tests due to technical reasons. NP: not performed.
| Breeding Pair | Number of Eggs | Fertilization Fertile Infertile | PaBV-4 RT PCR Embryo | Virus Isolation Embryo | Virus Isolation Egg Yolk | Dead Embryos | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Positive | Negative | Positive | Negative | Positive | Negative | |||||
| Pair 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | NP | NP | 0 |
| Pair 2 | 4 | 3 | 0 | 0 | 3 | 0 | 3 | NP | NP | 0 |
| 0 | 1 | NP | NP | NP | NP | 0 | 1 | |||
| Pair 3 | 31 | 27 | 0 | 15 | 12 | 0 | 27 | 6 | 14 | 1 |
| 0 | 4 | NP | NP | NP | NP | 0 | 1 | |||
| Pair 4 | 10 | 0 | 10 | NP | NP | NP | NP | 0 | 10 | 0 |
| Pair 5 | 3 | 0 | 3 | NP | NP | NP | NP | 0 | 3 | 0 |
Table 4.
Juvenile infected cockatiels: vertical transmission. Pairs marked with * were nesting in a group. Therefore, it was not possible to know which birds laid which eggs. Not all embryos were examined in all tests due to technical reasons. NP: not performed.
Table 4.
Juvenile infected cockatiels: vertical transmission. Pairs marked with * were nesting in a group. Therefore, it was not possible to know which birds laid which eggs. Not all embryos were examined in all tests due to technical reasons. NP: not performed.
| Female Bird Group J | Number of Eggs | Fertilization Fertile Infertile | PaBV-4 RT PCR Embryo | Virus Isolation Embryo | Virus Isolation Egg Yolk | Dead Embryos | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Positive | Negative | Positive | Negative | Positive | Negative | |||||
| Pairs 1 and 2 * | 31 | 18 | 0 | 15 | 3 | 6 | 9 | 6 | 1 | 10 |
| 0 | 13 | NP | NP | NP | NP | 0 | 12 | |||
| Pair 2 | 3 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 |
| 0 | 2 | NP | NP | NP | NP | 0 | 2 | |||
| Pair 3 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | NP | NP | 1 |
| Pair 4 | 8 | 8 | 0 | 8 | 0 | 2 | 3 | 4 | 1 | 0 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Link, J.; Herzog, S.; Gartner, A.M.; Bücking, B.; König, M.; Lierz, M. Factors Influencing Vertical Transmission of Psittacine Bornavirus in Cockatiels (Nymphicus hollandicus). Viruses 2022, 14, 2721. https://doi.org/10.3390/v14122721
AMA Style
Link J, Herzog S, Gartner AM, Bücking B, König M, Lierz M. Factors Influencing Vertical Transmission of Psittacine Bornavirus in Cockatiels (Nymphicus hollandicus). Viruses. 2022; 14(12):2721. https://doi.org/10.3390/v14122721
Chicago/Turabian StyleLink, Jessica, Sibylle Herzog, Anna Maria Gartner, Bianca Bücking, Matthias König, and Michael Lierz. 2022. "Factors Influencing Vertical Transmission of Psittacine Bornavirus in Cockatiels (Nymphicus hollandicus)" Viruses 14, no. 12: 2721. https://doi.org/10.3390/v14122721
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.
